Evidence map›Paper›PMID 35710448›Full record

ArticleTrials2022

Internet-based vestibular rehabilitation versus standard care after acute onset vertigo: a study protocol for a randomized controlled trial.

Solmaz Surano, Helena Grip, Fredrik Öhberg, Marcus Karlsson, Erik Faergemann, Maria Bjurman, Hugo Davidsson, Torbjörn Ledin, Ellen Lindell, Jan Mathé and 4 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05056324 (Internet-based Vestibular Rehabilitation Versus Standard Care After Acute Onset Vertigo), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05056324 nacompletednot on this map

Internet-based Vestibular Rehabilitation Versus Standard Care After Acute Onset Vertigo

TypeinterventionalSponsorUmeå UniversityRan2021 to 2025Enrolled184ConditionsAcute Vestibular SyndromeArmsOnline vestibular rehabilitation tool, Standard care (written instructions leaflet)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Solmaz SuranoDepartment of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
Helena GripDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Fredrik ÖhbergDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Marcus KarlssonDepartment of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
Erik FaergemannDepartment of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
Maria BjurmanSollefteå Hospital, Region Västernorrland, Sollefteå, Sweden.
Hugo DavidssonDepartment of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Torbjörn LedinDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Ellen LindellDepartment of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jan MathéDepartment of Clinical Neuroscience, Karolinska Institutet and Capio S:t Görans Hospital, Stockholm, Sweden.
Fredrik TjernströmDepartment of Clinical Sciences, Othorhinolaryngology, Lund University, Lund, Sweden.
Tatjana TomanovicDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Gabriel GranåsenDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Jonatan SalzerDepartment of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden. jonatan.salzer@umu.se.ORCID http://orcid.org/0000-0002-9205-0771
Umeå University · SEKarolinska Institutet · SELinköping University · SELund University · SERegion Västra Götaland · SESahlgrenska University Hospital · SESollefteå Hospital · SESundsvall Municipality · SE

Funding

Vetenskapsrådet 2020-00301
6 · The paper itself

Abstract

backgroundDizziness and vertigo affect around 15% of adults annually and represent common reasons for contacting health services, accounting for around 3% of all emergency department visits worldwide. Vertigo is also associated with excessive use of diagnostic imaging and emergency care and decreased productivity, primarily because of work absenteeism. Vestibular rehabilitation is an evidence-based treatment for chronic dizziness and supervised group exercise therapy has recently been shown to be effective after vestibular neuritis, a common cause of acute onset vertigo. However, such interventions are not readily available and there is a need for more easily accessible tools. The purpose of this study is to investigate the effects on vestibular symptoms of a 6-week online vestibular rehabilitation tool after acute onset vertigo, with the aim of aiding vestibular rehabilitation by presenting a more accessible tool that can help to reduce recovery time.

methodsThree hundred twenty individuals diagnosed with acute vestibular syndrome (AVS) will be recruited from multiple hospitals in Sweden and the effects of an online vestibular rehabilitation tool, YrselTräning, on vestibular symptoms after acute onset vertigo will be compared to standard care (written instructions leaflet) in a two-armed, evaluator-blinded, multicenter randomized controlled trial. The primary outcome will be the Vertigo Symptom Scale Short Form (VSS-SF) score at 6 weeks after symptom onset. Secondary outcomes include effects of the intervention on activities of daily living, mood and anxiety, vestibular function recovery, mobility measures, health economic effects, and the reliability of the Swedish VSS-SF translation. DISCUSSION: Participants using the online vestibular rehabilitation tool are expected to recover earlier and to a greater extent from their symptoms as compared to standard care. Since up to 50% of people with AVS without treatment develop persistent symptoms, effective treatment of AVS will likely lead to a higher quality of life and help reduce the societal costs associated with dizziness and vertigo.

trial registrationClinicaltrials.gov NCT05056324 . Registered on September 24, 2021.

Indexed as

DizzinessQuality of LifeActivities of Daily LivingAdultHumansInternetMulticenter Studies as TopicRandomized Controlled Trials as TopicReproducibility of ResultsVertigoAcute onset vertigoAVSGait functionInternet-based rehabilitationMulticenterOnline toolPortable motion sensorsRandomized controlled trialRCTVestibular rehabilitation

Identifiers

PMID35710448
PMCPMC9205069
OpenAlexW4283027741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.